Vanguard Group Inc Codexis, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,152,719 shares of CDXS stock, worth $21.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,152,719
Previous 4,091,230
1.5%
Holding current value
$21.9 Million
Previous $12.7 Million
0.85%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CDXS
# of Institutions
125Shares Held
59.9MCall Options Held
25.9KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.77MShares$46.3 Million4.93% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$42.8 Million1.94% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$35.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.97MShares$15.7 Million0.54% of portfolio
-
Telemark Asset Management, LLC Boston, MA2.7MShares$14.2 Million0.89% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $346M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...